Cargando…
Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta‐analysis
Lentinan is a common biological response modifier. This study was sought to evaluate the efficacy of adjuvant lentinan combined with chemotherapy for advanced cancer. A meta‐analysis of published prospective controlled trials investigating the effects of lentinan for kinds of advanced cancer was per...
Autores principales: | Wang, Hui, Cai, Yong, Zheng, Yue, Bai, Qixuan, Xie, Dongling, Yu, Jiufei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633561/ https://www.ncbi.nlm.nih.gov/pubmed/28940986 http://dx.doi.org/10.1002/cam4.1156 |
Ejemplares similares
-
Inhibition of Aflatoxin Synthesis in Aspergillus flavus by Three Structurally Modified Lentinans
por: Ma, Jinyou, et al.
Publicado: (2014) -
The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial
por: Zhao, Qun, et al.
Publicado: (2020) -
The Use of Lentinan for Treating Gastric Cancer
por: Ina, Kenji, et al.
Publicado: (2013) -
Green synthesis of palladium nanoparticles using lentinan for catalytic activity and biological applications
por: Han, Zengsheng, et al.
Publicado: (2019) -
Lentinan improved the efficacy of vaccine against Trichinella spiralis in an NLRP3 dependent manner
por: Jin, Xuemin, et al.
Publicado: (2020)